Commonwealth Equity Services
TRIB

Commonwealth Equity Services’s Trinity Biotech TRIB Stock Holding History

Commonwealth Equity Services’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,600
Closed -$13K – 4449
2025
Q3 		$13K Buy
+12,600
New +$13.2K ﹤0.01% 4219

Other funds holding TRIB

HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
WN
Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return
MAWA
Moss Adams Wealth Advisors Seattle, Washington $1.37B AUM 19.97% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Commonwealth Equity Services's TRIB Position: Q4 2025 in Review

Commonwealth Equity Services sold out of Trinity Biotech (TRIB) in Q4 2025, closing a stake of 12,600 shares — an estimated $13K sold.

Commonwealth Equity Services first reported a position in TRIB in Q3 2025 and held it in 1 quarter. The position peaked at $13K in Q3 2025. 27 funds tracked by Wall St. Rank hold TRIB as of Q4 2025.

  • Commonwealth Equity Services reported no remaining Trinity Biotech position as of Q4 2025 after selling out during the quarter.
  • Commonwealth Equity Services sold 12,600 Trinity Biotech shares in Q4 2025, an estimated $13K.
  • Commonwealth Equity Services first reported a position in Trinity Biotech in Q3 2025 and held it in 1 quarter.
  • Commonwealth Equity Services's Trinity Biotech position peaked at $13K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2025.

Based on Commonwealth Equity Services's 13F filing for Q4 2025, filed 12 Feb 2026.